{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:23:23Z","timestamp":1774463003197,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"F\u00f6rderclub Mastzellforschung e.V., Germany"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00251-017-0981-y","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T11:27:47Z","timestamp":1491478067000},"page":"359-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing"],"prefix":"10.1007","volume":"69","author":[{"given":"Janine","family":"Altm\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Haenisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kawalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Menzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus M.","family":"N\u00f6then","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heide","family":"Fier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard J.","family":"Molderings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"issue":"7571","key":"981_CR1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"1000 Genomes Project Consortium","year":"2015","unstructured":"1000 Genomes Project Consortium (2015) A global reference for human genetic variation. Nature 526(7571):68\u201374","journal-title":"Nature"},{"key":"981_CR2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/07853890.2016.1161231","volume":"48","author":"LB Afrin","year":"2016","unstructured":"Afrin LB, Butterfield J, Raithel M, Molderings GJ (2016) Mast cell activation disease: often seen, rarely recognized. Ann Med 48:190\u2013201","journal-title":"Ann Med"},{"key":"981_CR3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","volume":"126","author":"C Akin","year":"2010","unstructured":"Akin C, Valent P, Metcalfe D (2010) Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol 126:1099\u20131104","journal-title":"J Allergy Clin Immunol"},{"key":"981_CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1478-3231.2008.01839.x","volume":"29","author":"K Alfter","year":"2009","unstructured":"Alfter K, von K\u00fcgelgen I, Haenisch B, Frieling T, H\u00fclsdonk A, Haars U, Rolfs A, Noe G, Kolck UW, Homann J, Molderings GJ (2009) New aspects of liver abnormalities as part of the systemic mast cell activation syndrome. Liver Int 29:181\u2013186","journal-title":"Liver Int"},{"key":"981_CR5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ygyno.2008.12.036","volume":"113","author":"KA Ashton","year":"2009","unstructured":"Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ (2009) Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. Gynecol Oncol 113:109\u2013114","journal-title":"Gynecol Oncol"},{"key":"981_CR6","doi-asserted-by":"crossref","first-page":"e85362","DOI":"10.1371\/journal.pone.0085362","volume":"9","author":"G Damaj","year":"2014","unstructured":"Damaj G, Joris M, Chandesris O, Hanssens K, Soucie E, Canioni D, Kolb B, Durieu I, Gyan E, Livideanu C, Ch\u00e8ze S, Diouf M, Garidi R, Georgin-Lavialle S, Asnafi V, Lhermitte L, Lavigne C, Launay D, Arock M, Lortholary O, Dubreuil P, Hermine O (2014) ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases. PLoS One 9:e85362","journal-title":"PLoS One"},{"key":"981_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergencyto.2009.05.009","volume":"195","author":"TN Do","year":"2009","unstructured":"Do TN, Ucisik-Akkaya E, Davis CF, Morrison BA, Dorak MT (2009) TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility. Cancer Genet Cytogenet 195:31\u201336","journal-title":"Cancer Genet Cytogenet"},{"key":"981_CR8","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","volume":"108","author":"AC Garcia-Montero","year":"2006","unstructured":"Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A, Aldanondo I, Sanchez L, Dominguez M, Botana LM, Sanchez-Jimenez F, Sotlar K, Almeida J, Escribano L, Orfao A (2006) KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish network on Mastocytosis (REMA) in a series of 113 patients. Blood 108:2366\u20132372","journal-title":"Blood"},{"key":"981_CR9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaci.2011.09.029","volume":"129","author":"M Granada","year":"2012","unstructured":"Granada M, Wilk JB, Tuzova M, Strachan DP, Weidinger S, Albrecht E, Gieger C, Heinrich J, Himes BE, Hunninghake GM, Celed\u00f3n JC, Weiss ST, Cruikshank WW, Farrer LA, Center DM, O\u2019Connor GT (2012) A genome-wide association study of plasma total IgE concentrations in the Framingham heart study. J Allergy Clin Immunol 129:840\u2013845","journal-title":"J Allergy Clin Immunol"},{"key":"981_CR10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","volume":"128","author":"MJ Hamilton","year":"2011","unstructured":"Hamilton MJ, Hornick JL, Akin C, Castells MC, Greenberger NJ (2011) Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol 128:147\u2013152","journal-title":"J Allergy Clin Immunol"},{"key":"981_CR11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3324\/haematol.2013.095133","volume":"99","author":"K Hanssens","year":"2014","unstructured":"Hanssens K, Brenet F, Agopian J, Georgin-Lavialle S, Damaj G, Cabaret L, Chandesris MO, de Sepulveda P, Hermine O, Dubreuil P, Soucie E (2014) SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes. Haematologica 99:830\u2013835","journal-title":"Haematologica"},{"key":"981_CR12","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","volume":"3","author":"O Hermine","year":"2008","unstructured":"Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, Cohen-Akenine A, Palm\u00e9rini F, Hanssens K, Yang Y, Sobol H, Fraytag S, Ghez D, Suarez F, Barete S, Casassus P, Sans B, Arock M, Kinet JP, Dubreuil P, Moussy A (2008) Case-control cohort study of patients\u2019 perceptions of disability in mastocytosis. PLoS One 3:e2266","journal-title":"PLoS One"},{"key":"981_CR13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/leu.2015.4","volume":"29","author":"M Jawhar","year":"2015","unstructured":"Jawhar M, Schwaab J, Schnittger S, Sotlar K, Horny HP, Metzgeroth G, M\u00fcller N, Schneider S, Naumann N, Walz C, Haferlach T, Valent P, Hofmann WK, Cross NC, Fabarius A, Reiter A (2015) Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event. Leukemia 29:1115\u20131122","journal-title":"Leukemia"},{"key":"981_CR14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/leu.2015.284","volume":"30","author":"M Jawhar","year":"2016","unstructured":"Jawhar M, Schwaab J, Schnittger S, Meggendorfer M, Pfirrmann M, Sotlar K, Horny HP, Metzgeroth G, Kluger S, Naumann N, Haferlach C, Haferlach T, Valent P, Hofmann WK, Fabarius A, Cross NC, Reiter A (2016) Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis. Leukemia 30:136\u2013143","journal-title":"Leukemia"},{"key":"981_CR15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/hmg\/ddm050","volume":"16","author":"N Johnson","year":"2007","unstructured":"Johnson N, Fletcher O, Palles C, Rudd M, Webb E, Sellick G, dos Santos SI, McCormack V, Gibson L, Fraser A, Leonard A, Gilham C, Tavtigian SV, Ashworth A, Houlston R, Peto J (2007) Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. Hum Mol Genet 16:1051\u20131057","journal-title":"Hum Mol Genet"},{"key":"981_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.2012.01789.x","volume":"89","author":"T Kristensen","year":"2012","unstructured":"Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, M\u00f8ller MB, on behalf of the Mastocytosis Centre Odense University Hospital (MastOUH) (2012) Circulating KIT D816V mutation positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis. Eur J Haematol 89:42\u201346","journal-title":"Eur J Haematol"},{"key":"981_CR17","doi-asserted-by":"crossref","first-page":"e1000481","DOI":"10.1371\/journal.pgen.1000481","volume":"5","author":"B Li","year":"2009","unstructured":"Li B, Leal SM (2009) Discovery of rare variants via sequencing: implications for the design of complex trait association studies. PLoS Genet 5:e1000481","journal-title":"PLoS Genet"},{"key":"981_CR18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","volume":"96","author":"BJ Longley","year":"1999","unstructured":"Longley BJ, Metcalfe DD, Tharp M, Wang X, Tyrrell L, Lu SZ, Heitjan D, Ma Y (1999) Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci 96:1609\u20131614","journal-title":"Proc Natl Acad Sci"},{"key":"981_CR19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","volume":"126","author":"LY McGirt","year":"2015","unstructured":"McGirt LY, Jia P, Baerenwald DA, Duszynski RJ, Dahlman KB, Zic JA, Zwerner JP, Hucks D, Dave U, Zhao Z, Eischen CM (2015) Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood 126:508\u2013519","journal-title":"Blood"},{"key":"981_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2014.09.001","volume":"93","author":"GJ Molderings","year":"2015","unstructured":"Molderings GJ (2015) The genetic basis of mast cell activation disease - looking through a glass darkly. Crit Rev Oncol Hematol 93:75\u201389","journal-title":"Crit Rev Oncol Hematol"},{"key":"981_CR21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","volume":"42","author":"GJ Molderings","year":"2007","unstructured":"Molderings GJ, Kolck UW, Scheurlen C, Br\u00fcss M, Homann J, Von K\u00fcgelgen I (2007) Multiple novel alterations in kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder. Scand J Gastroenterol 42:1045\u20131053","journal-title":"Scand J Gastroenterol"},{"key":"981_CR22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00251-010-0474-8","volume":"62","author":"GJ Molderings","year":"2010","unstructured":"Molderings GJ, Meis K, Kolck UW, Homann J, Frieling T (2010) Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects. Immunogenetics 62:721\u2013727","journal-title":"Immunogenetics"},{"key":"981_CR23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","volume":"4","author":"GJ Molderings","year":"2011","unstructured":"Molderings GJ, Brettner S, Homann J, Afrin LB (2011) Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol 4:10","journal-title":"J Hematol Oncol"},{"key":"981_CR24","first-page":"e76241","volume":"8","author":"GJ Molderings","year":"2013","unstructured":"Molderings GJ, Haenisch B, Bogdanow M, Fimmers R, N\u00f6then MM (2013) Familial occurrence of systemic mast cell activation disease PLoS One 8:e76241","journal-title":"Familial occurrence of systemic mast cell activation disease PLoS One"},{"key":"981_CR25","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","volume":"92","author":"H Nagata","year":"1995","unstructured":"Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD (1995) Identification of a point mutation in the catalytic domain of the protooncogene c- kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci 92:10560\u201310564","journal-title":"Proc Natl Acad Sci"},{"key":"981_CR26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11:863\u2013874","journal-title":"Genome Res"},{"key":"981_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-007-9821-3","volume":"112","author":"T Rajkumar","year":"2008","unstructured":"Rajkumar T, Samson M, Rama R, Sridevi V, Mahji U, Swaminathan R, Nancy NK (2008) TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy. Breast Cancer Res Treat 112:81\u201387","journal-title":"Breast Cancer Res Treat"},{"key":"981_CR28","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1093\/nar\/gkf493","volume":"30","author":"V Ramensky","year":"2002","unstructured":"Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894\u20133900","journal-title":"Nucleic Acids Res"},{"key":"981_CR29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2162-3619-3-18","volume":"3","author":"M Rechsteiner","year":"2014","unstructured":"Rechsteiner M, M\u00fcller R, Reineke T, Goede J, Bohnert A, Zhong Q, Manz MG, Moch H, Wild PJ, Zimmermann DR, Tinguely M (2014) Modelling of a genetically diverse evolution of systemic Mastocytosis with chronic Myelomonocytic leukemia (SM-CMML) by next generation sequencing. Exp Hematol Oncol 3:18","journal-title":"Exp Hematol Oncol"},{"key":"981_CR30","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","volume":"122","author":"J Schwaab","year":"2013","unstructured":"Schwaab J, Schnittger S, Sotlar K, Walz C, Fabarius A, Pfirrmann M, Kohlmann A, Grossmann V, Meggendorfer M, Horny HP, Valent P, Jawhar M, Teichmann M, Metzgeroth G, Erben P, Ernst T, Hochhaus A, Haferlach T, Hofmann WK, Cross NC, Reiter A (2013) Comprehensive mutational profiling in advanced systemic mastocytosis. Blood 122:2460\u20132466","journal-title":"Blood"},{"key":"981_CR31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/hmg\/10.6.591","volume":"10","author":"S Sunyaev","year":"2001","unstructured":"Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, Bork P (2001) Prediction of deleterious human alleles. Hum Mol Genet 10:591\u2013597","journal-title":"Hum Mol Genet"},{"key":"981_CR32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2011.293","volume":"26","author":"C Teodosio","year":"2012","unstructured":"Teodosio C, Garc\u00eda-Montero AC, Jara-Acevedo M, Alvarez-Twose I, S\u00e1nchez-Mu\u00f1oz L, Almeida J, Morgado JM, Matito A, Escribano L, Orfao A (2012) An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis. Leukemia 26:951\u2013958","journal-title":"Leukemia"},{"key":"981_CR33","doi-asserted-by":"crossref","first-page":"e43090","DOI":"10.1371\/journal.pone.0043090","volume":"7","author":"F Traina","year":"2012","unstructured":"Traina F, Visconte V, Jankowska AM, Makishima H, O'Keefe CL, Elson P, Han Y, Hsieh FH, Sekeres MA, Mali RS, Kalaycio M, Lichtin AE, Advani AS, Duong HK, Copelan E, Kapur R, Olalla Saad ST, Maciejewski JP, Tiu RV (2012) Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PLoS One 7:e43090","journal-title":"PLoS One"},{"key":"981_CR34","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jnci\/djr516","volume":"104","author":"KY Urayama","year":"2012","unstructured":"Urayama KY, Jarrett RF, Hjalgrim H, Diepstra A, Kamatani Y, Chabrier A, Gaborieau V, Boland A, Nieters A, Becker N, Foretova L, Benavente Y, Maynadi\u00e9 M, Staines A, Shield L, Lake A, Montgomery D, Taylor M, Smedby KE, Amini RM, Adami HO, Glimelius B, Feenstra B, Nolte IM, Visser L, van Imhoff GW, Lightfoot T, Cocco P, Kiemeney L, Vermeulen SH, Holcatova I, Vatten L, Macfarlane GJ, Thomson P, Conway DI, Benhamou S, Agudo A, Healy CM, Overvad K, Tj\u00f8nneland A, Melin B, Canzian F, Khaw KT, Travis RC, Peeters PH, Gonz\u00e1lez CA, Quir\u00f3s JR, S\u00e1nchez MJ, Huerta JM, Ardanaz E, Dorronsoro M, Clavel-Chapelon F, Bueno-de-Mesquita HB, Riboli E, Roman E, Boffetta P, de Sanjos\u00e9 S, Zelenika D, Melbye M, van den Berg A, Lathrop M, Brennan P, McKay JD (2012) Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst 104:240\u2013253","journal-title":"J Natl Cancer Inst"},{"key":"981_CR35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"P Valent","year":"2007","unstructured":"Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Investig 37:435\u2013453","journal-title":"Eur J Clin Investig"},{"key":"981_CR36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","volume":"157","author":"P Valent","year":"2012","unstructured":"Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, Castells M, Escribano L, Hartmann K, Lieberman P, Nedoszytko B, Orfao A, Schwartz LB, Sotlar K, Sperr WR, Triggiani M, Valenta R, Horny HP, Metcalfe DD (2012) Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 157:215\u2013225","journal-title":"Int Arch Allergy Immunol"},{"key":"981_CR37","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ygeno.2003.12.016","volume":"83","author":"T Xi","year":"2004","unstructured":"Xi T, Jones IM, Mohrenweiser HW (2004) Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 83:970\u2013979","journal-title":"Genomics"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00251-017-0981-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-017-0981-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-017-0981-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T04:31:59Z","timestamp":1494995519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00251-017-0981-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["981"],"URL":"https:\/\/doi.org\/10.1007\/s00251-017-0981-y","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]}}}